Insulin Independence: Is This the Future for Type 1 Diabetes Patients?
![ADA-83rd-Sci-Sessions-Logo](https://nationalstemcelltherapy.com/wp-content/uploads/2023/06/American-Diabetes-Association-Scientific-Sessions-1024x278.jpg)
The press release from the American Diabetes Association presents promising findings from an ongoing clinical trial of VX-880, a novel stem cell-derived islet cell therapy for individuals with type 1 diabetes (T1D). The study, presented at the 83rd Scientific Sessions of the American Diabetes Association, demonstrates the potential of this therapy as a future treatment […]